BA vs ZYME · P/E 89, rev $89.46B vs rev $76.3M
The Boeing Company (BA) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
BA currently screens at market cap $177.86B and trailing P/E 89.2. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the BA and ZYME stock pages for the full models.
Not investment advice.